{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:21:32Z","timestamp":1777656092731,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13300-015-0137-8","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T09:41:11Z","timestamp":1444815671000},"page":"519-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry"],"prefix":"10.1007","volume":"6","author":[{"given":"Linong","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Tzer","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv","family":"Bhambani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"issue":"Suppl 1","key":"137_CR1","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.2337\/diacare.28.suppl_1.S37","volume":"28","author":"American Diabetes Association","year":"2005","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28(Suppl 1):S37\u201342.","journal-title":"Diabetes Care."},{"key":"137_CR2","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/dc05-2179","volume":"29","author":"MA Abdul-Ghani","year":"2006","unstructured":"Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29:1130\u20139.","journal-title":"Diabetes Care"},{"key":"137_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977\u201386.","journal-title":"N Engl J Med"},{"key":"137_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577\u201389.","journal-title":"N Engl J Med"},{"key":"137_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405\u201312.","journal-title":"BMJ"},{"key":"137_CR6","unstructured":"International Diabetes Federation. IDF Clinical Guidelines Task Force. Global guideline for Type 2 diabetes. International Diabetes Federation. http:\/\/www.idf.org\/global-guideline-type-2-diabetes-2005 . Accessed 3 Dec 2013."},{"key":"137_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Assocation and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140\u20139.","journal-title":"Diabetes Care"},{"key":"137_CR8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1185\/03007990802292728","volume":"24","author":"A Liebl","year":"2008","unstructured":"Liebl A, Breitscheidel L, Nicolay C, Happich M. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study. Curr Med Res Opin. 2008;24:2349\u201358.","journal-title":"Curr Med Res Opin."},{"key":"137_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1185\/03007990903417679","volume":"26","author":"GA Nichols","year":"2010","unstructured":"Nichols GA, Gandra SR, Chiou CF, Anthony MS, Alexander-Bridges M, Brown JB. Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting. Curr Med Res Opin. 2010;26:9\u201315.","journal-title":"Curr Med Res Opin"},{"key":"137_CR10","first-page":"598","volume":"13","author":"AJ Karter","year":"2007","unstructured":"Karter AJ, Moffet HH, Liu J, et al. Glycemic response to newly initiated diabetes therapies. Am J Manag Care. 2007;13:598\u2013606.","journal-title":"Am J Manag Care"},{"key":"137_CR11","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 6th edn. Brussels, Belgium. International Diabetes Federation. http:\/\/www.idf.org\/diabetesatlas . Accessed 3 Dec 2013."},{"key":"137_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2337\/dc08-0435","volume":"32","author":"JC Chan","year":"2009","unstructured":"Chan JC, Gagliardino JJ, Baik SH, et al. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care. 2009;32:227\u201333.","journal-title":"Diabetes Care"},{"key":"137_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1185\/030079908X261131","volume":"24","author":"M Mohamed","year":"2008","unstructured":"Mohamed M. An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies. Curr Med Res Opin. 2008;24:507\u201314.","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 2","key":"137_CR14","first-page":"B21","volume":"23","author":"M Shichiri","year":"2000","unstructured":"Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(Suppl 2):B21\u20139.","journal-title":"Diabetes Care"},{"key":"137_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1753-0407.2011.00137.x","volume":"3","author":"ST Tsai","year":"2011","unstructured":"Tsai ST, Pathan F, Ji L, et al. First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia. J Diabetes. 2011;3:208\u201316.","journal-title":"J Diabetes"},{"key":"137_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3109\/13697137.2011.555886","volume":"14","author":"DA Tan","year":"2011","unstructured":"Tan DA. Changing disease trends in the Asia\u2013Pacific. Climacteric. 2011;14:529\u201334.","journal-title":"Climacteric"},{"key":"137_CR17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4103\/IJMR.2010_132_05_584","volume":"132","author":"MK Ali","year":"2010","unstructured":"Ali MK, Narayan KM, Tandon N. Diabetes & coronary heart disease: current perspectives. Indian J Med Res. 2010;132:584\u201397.","journal-title":"Indian J Med Res"},{"issue":"Suppl 3","key":"137_CR18","first-page":"S12","volume":"93","author":"T Pratipanawatr","year":"2010","unstructured":"Pratipanawatr T, Rawdaree P, Chetthakul T, et al. Thailand Diabetic Registry cohort: predicting death in Thai diabetic patients and causes of death. J Med Assoc Thai. 2010;93(Suppl 3):S12\u201320.","journal-title":"J Med Assoc Thai"},{"key":"137_CR19","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","volume":"371","author":"J Weng","year":"2008","unstructured":"Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet. 2008;371:1753\u201360.","journal-title":"Lancet"},{"key":"137_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1464-5491.2011.03416.x","volume":"29","author":"S Barendse","year":"2012","unstructured":"Barendse S, Singh H, Frier BM, Speight J. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review. Diabet Med. 2012;29:293\u2013302.","journal-title":"Diabet Med"},{"key":"137_CR21","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.clinthera.2007.07.004","volume":"29","author":"RJ Ligthelm","year":"2007","unstructured":"Ligthelm RJ, Borzi V, Gumprecht J, Kawamori R, Wenying Y, Valensi F. Importance of observational studies in clinical practice. Clin Ther. 2007;29:1284\u201392.","journal-title":"Clin Ther"},{"key":"137_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.diabres.2011.10.021","volume":"94","author":"PD Home","year":"2011","unstructured":"Home PD, El Naggar N, Khamseh M, Gonzalez-Galvez G, Shen C, et al. An observational, non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study. Diabetes Res Clin Pract. 2011;94:352\u201363.","journal-title":"Diabetes Res Clin Pract"},{"key":"137_CR23","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1111\/j.1742-1241.2008.01917.x","volume":"62","author":"P Valensi","year":"2008","unstructured":"Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, et al. The IMPROVE study: a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. Int J Clin Pract. 2008;62:1809\u201319.","journal-title":"Int J Clin Pract"},{"key":"137_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1185\/03007990902840871","volume":"25","author":"LF Meneghini","year":"2009","unstructured":"Meneghini LF, Donhorst A, Sreenan S, the PREDICTIVE Study Group. Once-daily insulin detemir in a cohort of insulin-naive patients with type 2 diabetes: a sub-analysis of the PREDICTIVE study. Curr Med Res Opin. 2009;25:1029\u201335.","journal-title":"Curr Med Res Opin"},{"key":"137_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1463-1326.2007.00826.x","volume":"10","author":"D Khutsoane","year":"2008","unstructured":"Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, et al. Biphasic insulin aspart 30 treatment improves glycemic control in patients with type 2 diabetes in a clinical practice setting. Diabetes Obes Metab. 2008;10:212\u201322.","journal-title":"Diabetes Obes Metab"},{"key":"137_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.diabres.2015.01.030","volume":"108","author":"PD Home","year":"2015","unstructured":"Home PD, Dain MP, Freemantle N, Kawamori R, Pfohl M, et al. Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents. Diabetes Res Clin Pract. 2015;108:350\u20139.","journal-title":"Diabetes Res Clin Pract"},{"key":"137_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4172\/2155-6156.1000165","volume":"2","author":"I Eland","year":"2011","unstructured":"Eland I, Heintjes E, Houweling L, deGrooth R, Veneman TF, Bouter KP. Insulin glargine versus insulin detemir: glycemic control and insulin dose in type 2 diabetes mellitus patients using a medical record linkage system in The Netherlands. J Diabetes Metab. 2011;2:165.","journal-title":"J Diabetes Metab"},{"key":"137_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-007-0911-x","volume":"51","author":"J Rosenstock","year":"2008","unstructured":"Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia. 2008;51:408\u201316.","journal-title":"Diabetologia"},{"key":"137_CR29","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.2337\/dc09-2294","volume":"33","author":"SG Swinnen","year":"2010","unstructured":"Swinnen SG, Dain MP, Aronson R, et al. A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs. Diabetes Care. 2010;33:1176\u20138.","journal-title":"Diabetes Care"},{"key":"137_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2337\/dc08-2117","volume":"32","author":"JB Buse","year":"2009","unstructured":"Buse JB, Wolffenbuttel BH, Herman WH, et al. DURAbility of basal versus lispro mix 75\/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75\/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes. Diabetes Care. 2009;32:1007\u201313.","journal-title":"Diabetes Care"},{"key":"137_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.diabres.2014.08.003","volume":"106","author":"DR Owens","year":"2015","unstructured":"Owens DR, Traylor L, Dain MP, Landgraf W. Efficacy and safety of basal insulin glargine 12 and 24\u00a0weeks after initiation in persons with type 2 diabetes: a pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials. Diabetes Res Clin Pract. 2015;106:264\u201374.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-015-0137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13300-015-0137-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-015-0137-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-015-0137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T01:12:11Z","timestamp":1748653931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-015-0137-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["137"],"URL":"https:\/\/doi.org\/10.1007\/s13300-015-0137-8","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,14]]},"assertion":[{"value":"11 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2015","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}